Sickle Cell Disease

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
hydroxyurea HYDROXYUREA CAPSULE Y    
hydroxyurea HYDREA CAPSULE Y    
crizanlizumab-tmca ADAKVEO VIAL N PA Document  
glutamine ENDARI POWD PACK N PA Document  
hydroxyurea DROXIA CAPSULE N    
hydroxyurea SIKLOS TABLET N    
voxelotor OXBRYTA TAB SUSP N PA Document  
voxelotor OXBRYTA TABLET N PA Document